about
Cytomegalovirus-induced immunopathology and its clinical consequencesBioactive Molecules Released From Cells Infected with the Human CytomegalovirusIsolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.Occult cytomegalovirus in vivarium-housed mice may influence transplant allograft acceptance.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Human cytomegalovirus infection dysregulates the canonical Wnt/β-catenin signaling pathway.HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.Natural killer cell dependent within-host competition arises during multiple MCMV infection: consequences for viral transmission and evolution.Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodiesLymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab InductionScanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism.The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97.HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors.Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in transDisruption of murine cardiac allograft acceptance by latent cytomegalovirus.Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomesGeneration of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells.Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope.Tegument proteins of human cytomegalovirusUnlinked memory helper responses promote long-lasting humoral alloimmunity.Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.Novel method based on "en passant" mutagenesis coupled with a gaussia luciferase reporter assay for studying the combined effects of human cytomegalovirus mutations.Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanismsCytomegalovirus infections in solid organ transplantation: a review.Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies.A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells.Chemokines encoded by herpesviruses.Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.Proteomic and phylogenetic coevolution analyses of pM79 and pM92 identify interactions with RNA polymerase II and delineate the murine cytomegalovirus late transcription complex.Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time.Murine cytomegalovirus protein pM92 is a conserved regulator of viral late gene expression.Entry of human cytomegalovirus into porcine endothelial cells depends on both the cellular vascular origin and the viral strain.Analysis of plasma surfactant protein D levels in lung transplant recipients.Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort.Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients.Human cytomegalovirus infection in lung transplant recipients triggers a CXCL-10 response.CMV infection in the donor and increased kidney graft loss: impact of full HLA-I mismatch and posttransplantation CD8(+) cell reduction.Expression levels of glycoprotein O (gO) vary between strains of human cytomegalovirus, influencing the assembly of gH/gL complexes and virion infectivity.
P2860
Q21195897-1934592D-D5AE-4AC9-A28B-BE4C18D8F3E6Q26744665-ABE51BDD-68D1-47D5-9B33-B53689246D44Q33558361-F68C25E2-5BE5-4C11-BE18-82E3D6734E6BQ33658817-192BDF26-03C1-4798-9182-116A4D4391FAQ33945476-4D7019A2-F90E-445A-AE95-64FA1897AAFEQ34360228-1E512A87-88F6-42C2-A3A0-4E276BC84AD3Q34446646-B29BE37A-3437-4B0F-87D7-626F8A0FEA9BQ34506165-1B720E21-4742-4A92-9DB0-00AE858D3B72Q34539825-ED747013-7DA2-454D-BF56-417B7550783FQ34753135-52D6DDD5-072C-4012-981C-C89B16F21B02Q35781773-29678A45-0737-4D73-ACBD-F91CB16FB6B9Q35866191-245FA1D9-B92C-49D5-B820-A82265440613Q35913890-7B736CFD-7A12-48A8-A3FC-2B1B4F88ADCCQ36827232-981D7CEF-5D3A-4EC4-AB9C-9AA863A51D90Q36893722-18C21210-AEFC-4AE1-BE13-08C087B217DDQ36974741-8CEDC06B-B436-43FD-A7EF-391C4FC6F302Q37060516-04F5737C-5913-4425-BCE9-48E1589A936FQ37070704-2AC65B42-7214-4A1B-B402-930D3A04518BQ37074285-6523C631-3482-4DBE-88C0-6FB0ED315799Q37123419-A71CF255-C42C-45F9-B934-D12B928076CFQ37183914-269EDA7D-7893-4FE0-888F-20A8343D2BB5Q37210784-3790B497-D532-4A9A-B1A3-C731D84EE421Q37211290-FC7AF12F-7BBE-4596-89C8-AC9B2D5101A6Q37264338-98544134-C73C-4936-AEA6-1DAE1EB10BCAQ37275085-1529A65D-BB3F-4260-9E3B-FE1187DAB653Q37359332-023B9233-06EF-48BC-BE51-E57247606201Q37778827-69D0AAEB-D3A2-4B86-A587-2B0C5331980CQ39035259-059530F6-68B4-4E10-AA79-729AB18CFF7FQ40067378-8B458A6B-DF9D-43F9-A837-1EF7A7938F83Q40232348-85564A7E-520A-4BC3-B65D-6A93DEF71741Q40420262-8174E1DC-02F2-4A43-9FDE-23BB07F43263Q41897136-A33D4520-3E06-41D1-A345-89108CFD1CD5Q41909097-F2EB5713-9620-465A-9093-FD6A7D9C931EQ42220221-3F441E49-6BAA-47F6-8540-811AC90120F1Q42270252-E501786E-92F4-47D8-8C90-A5F20B68F9FBQ43417727-C6719AFA-C0CD-40FC-870F-60F6CA8AE453Q43489588-A5991CC6-4D3D-4022-9C60-E77412FA0941Q43536491-22357B55-BFF6-4B64-8D36-244518BAFBBAQ51873058-6296B75A-8BC6-496E-B5C2-C6C80FB19693Q54216733-024E1393-397A-4F57-BBA0-148ADE44F5A2
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Acceleration of allograft failure by cytomegalovirus
@ast
Acceleration of allograft failure by cytomegalovirus
@en
type
label
Acceleration of allograft failure by cytomegalovirus
@ast
Acceleration of allograft failure by cytomegalovirus
@en
prefLabel
Acceleration of allograft failure by cytomegalovirus
@ast
Acceleration of allograft failure by cytomegalovirus
@en
P2093
P2860
P1476
Acceleration of allograft failure by cytomegalovirus
@en
P2093
Daniel N Streblow
Jay A Nelson
Susan L Orloff
P2860
P304
P356
10.1016/J.COI.2007.07.012
P577
2007-08-22T00:00:00Z